Introduction
Tuberculosis is largely a disease of poverty, and therefore children with the disease frequently live in poor communities with few health services. 1 Social, logistic, and fi nancial issues can mean that children are not brought for assessment after the development of symptoms, and even if they are assessed, a confi rmed diagnosis can be challenging because of a low bacillary load and diffi culties of specimen collection. 2 Therefore, a diagnosis is often made presumptively on the basis of a combination of clinical symptoms, signs, and radiological fi ndings. However, in regions where other diseases with overlapping features (eg, HIV, systemic viral or bacterial infections, parasitic infections, and bacterial, viral, or atypical pneumonia) are also endemic, the sensitivity and specifi city of these diagnostic approaches are imperfect. 3 Even children who are diagnosed and treated are often not recorded in registers or reported to national tuberculosis programmes, 4 meaning that the number of cases is diffi cult to establish directly. Childhood tuberculosis has been neglected by health programmers and academics, because children frequently have paucibacillary disease and are not thought to be infectious; from a public health perspective, they are deemed not to constitute a high risk of disease propagation within a community. 5 Additionally, the global community has not set paediatric-specifi c targets for reduction of the disease burden. Because of the absence of clear paediatric targets, perceptions of low public health importance, and challenges in presentation, diagnosis, treatment, and reporting, estimates of disease burden have not been prioritised.
Nevertheless, interest in paediatric tuberculosis is increasing, and in 2012, WHO presented estimates of the global burden in children for the fi rst time. 6 WHO started with the number of childhood tuberculosis cases reported to the organisation (for countries in which data are disaggregated into paediatric and adult cases) and then combined this number with an estimate of paediatric notifi cations for countries in which data are not disaggregated (calculated with the ratio between child and adult cases from the countries in which data are disaggregated). Because of the scarcity of evidence about how the gap between notifi cations and underlying disease incidence varies by age, this estimate of notifi ed cases in children was then infl ated to account for incomplete case detection with the global, all-ages case detection proportion of 66%, generating an estimate for the underlying tuberculosis incidence. This procedure yielded a global estimate of 490 000 tuberculosis cases per year (uncertainty interval 470 000-510 000) in children younger than 15 years, corresponding to 6% of the 8·7 million estimated incident cases in 2011. 6 Although WHO's approach was straightforward and transparent, diffi culties have been acknowledged with each step-ie, notifi cations for children, extrapolations for nonreporting countries, and especially the infl ation to account for undetected cases.
With a more complete understanding of the burden of tuberculosis in children, the children who are developing the disease could be identifi ed, which would allow programmes to target interventions where they are needed most and help with the rational planning of service and resource allocation. Identifi cation of discrepancies between the number of expected cases and the number of treated cases would allow targeting of health systems that are not fi nding, diagnosing, treating, or reporting appropriate numbers of child cases. From a public health perspective, children with tuberculosis represent recent transmission and can be judged as sentinel markers of disease transmission in the community and therefore as indicators of tuberculosis control. 7 Finally, an understanding of the likely burden of disease is key for advocacy and market assessments, and would be essential for motivation of the research and development of new diagnostics, vaccines, and drugs adapted for the needs of children as well as adults.
In light of the diffi culties with diagnosis and notifi cation of childhood tuberculosis, we aimed to develop a mecha nistic mathematical model to estimate the number of cases indirectly in the 22 countries with a high burden of tuberculosis. These countries are reported to harbour 80% of the global burden. 6 We estimated the incidence of infection and disease in children, the prevalence of infection, and household exposure. Because predictions are not based on childhood notifi cations, this method is independent of existing approaches, and can be compared with reporting.
Methods

Study design
We used the same workfl ow for each of the 22 countries included (fi gure 1). The age-stratifi ed population determined the total number of children at risk in each country (the denominator). Because most demographic data were available for 2010, we used epidemiological data from this year as well. We calculated exposure and infection with two techniques: one was based on a community model and the other on a detailed model of household exposure.
Community model
We combined WHO estimates of tuberculosis prevalence 6 with notifi cation data for 2010, stratifi ed by disease type (smear positive, smear negative, or extrapulmonary), to estimate the force of Mycobacterium tuberculosis infection in the 22 high-burden countries (HBCs). We modelled uncertainty in prevalence estimates with gamma distributions matched to the 95% ranges quoted for each country. We assumed a linear association between force of infection and tuberculosis prevalence, modelling the gradient by a Weibull distribution fi tted to pooled data from two reviews 8, 9 in which the ratio between annual risk of infection and prevalence of smear-positive tuberculosis 1 We computed infection prevalence with the survival function for escaping infection, assessed at the midpoints of the age groups.
Household model
As an alternative to modelling the risk of M tuberculosis infection, we estimated household exposure to infectious cases of tuberculosis for diff erent age groups, ignoring exposure outside the household. We obtained Demographic and Health Survey data describing the composition of households by age and sex for 16 of the 22 HBCs. We developed an in-silico representation of each population, and, for a specifi c prevalence, we used the relevant country's age and sex distribution of smearpositive notifi cations to distribute tuberculosis cases between individuals. We then computed the number of children in each age group in the same household as an individual of any age with tuberculosis, and repeated the process 10 000 times to obtain an estimate of the probability of household exposure. When household data for a country were not available, we imputed the association between tuberculosis prevalence and household exposure risk. We used the number of children cohabiting with an individual with tuberculosis to estimate the incidence of infection (via the household), modelling infection rates (based on contact studies [10] [11] [12] ) with a log normal distribution and assuming smear-negative tuberculosis to be on average 23% as infectious as smear-positive diseases.
13,14
Progression to disease
Probabilities of progression from infection to disease in each age group were modelled with beta distributions on the basis of Marais and colleagues' report, 15 as were the probabilities of the ensuing disease being pulmonary or extra-pulmonary. We modelled BCG vaccination effi cacy in prevention of extra-pulmonary disease and the fraction of this protection eff ective against pulmonary tuberculosis as beta distributions, on the basis of systematic reviews. 8, [16] [17] [18] As suggested by Palmer and colleagues, 19 we allowed a proportion of the effi cacy of BCG vaccination to vary with latitude (measured at the countries' capital cities), with effi cacy at the equator 59% of that at the poles. We used WHO estimates of BCG coverage for each country. We accounted for the eff ect of HIV infection on incidence by an incidence rate ratio, modelled as a log normal distribution, on the basis of a study of the eff ect of HIV infection on risk of tuberculosis in children. 20 HIV prevalence in those younger than 15 years was taken from data from the Joint United Nations Programme on HIV/ AIDS, and again we modelled uncertainty with gamma distributions and assumed prevalence to be zero where data were not available. We multiplied the estimates of the number of children with M tuberculosis infection in each age group by probabilities of progression, and then modifi ed values by the eff ects of BCG vaccination and HIV infection to arrive at estimates of incidence of paediatric tuberculosis by country, age group, and disease type.
Numerical methods
We constructed probability distributions representing uncertainty in estimated quantities with a Latin hypercube sample of size 50 000 from across all the distributions representing uncertainty in model parameters and input data. To assess the sensitivity to key structural assumptions, we repeated all analyses without variation in BCG effi cacy by latitude, and repeated the household analysis assuming a uniform distribution of tuberculosis cases by age and sex across adults. We did all computations in the R environment for statistical computing. Further details about the methods, including all parameter values, are in the appendix.
Role of the funding source
The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication. Table 1 shows the model estimates for children aged 0-1, 1-2, 2-5, 5-10, and 10-15 years. Tuberculosis exposure, infection, and disease was lower in under-5s than children aged 5-15 years. The most likely model prediction (the mode) is that about 500 000 cases of tuberculosis occurred in children younger than 15 years in the 22 HBCs in 2010 (fi gure 2). The median number of cases predicted was 650 977 (IQR 424 871-983 118). The median number of children younger than 15 years estimated to be sharing a household with an individual with infectious tuberculosis in the 22 HBCs was 15 319 701 (13 766 297-17 061 821), and the median number of M tuberculosis infections occurring in children younger than 15 years in 2010 was 7 591 759 (5 800 053-9 969 780). The cumulative incidence of infection yielded a median estimated number of children younger than 15 years with latent tuberculosis infection at the end of 2010 of 53 234 854 (41 111 669-68 959 804). The mode value for incidence of infection in the household was about 300 000 (fi gure 2). The median number of household infections was 396 078 (IQR 271 905-565 304).
Results
A uniform distribution of ages in the household model of exposure led to disease estimates that were 11% higher than the distribution based on adult age and sex notifi cations (appendix). An assumption that the effi cacy of BCG vaccination did not wane towards the equator resulted in disease estimates that were 27% lower for all methods of estimating infection (appendix).
The proportion of the total incidence of paediatric tuberculosis in the 22 HBCs occurring in children with See Online for appendix HIV infection was estimated at 5·0% (IQR 2·4-10·1). However, in both South Africa and Zimbabwe, this proportion was predicted to be more than 25% (appendix). Tuberculosis incidence at younger ages (<5 years) was predicted to make up 58% (IQR 40-77) of the total, and 23% (13-36) of the disease in this age group was predicted to be extrapulmonary (appendix). In all children younger than 15 years, 14% (8-22%) of disease was estimated to be extrapulmonary.
Discrepancies between the number of reported cases and estimated incidence were heterogeneous between countries but under-reporting was more pronounced in the younger age group (fi gure 3). India is predicted to account for 27% (22- 
Discussion
Overall, although the uncertainty ranges were large, our model predicted that about 7·6 million children younger than 15 years in the 22 HBCs became infected with M tuberculosis in 2010, and roughly 650 000 developed tuberculosis (panel). We have estimated that about 15 million children younger than 15 years in these countries were living in the same household as an adult with tuberculosis, and roughly 53 million children were estimated to be infected with M tuberculosis in 2010. These fi gures are medians for the corresponding probability distributions. We chose medians as a Bayes estimator with a linear penalty in the error, and to allow natural reporting of uncertainty ranges.
As far as we are aware, we are the fi rst to attempt to estimate the burden of childhood tuberculosis with a mechanistic model, using prevalence of tuberculosis in adults to estimate rates of infection and disease in children. We used an updated version of Styblo's rule 8, 9 to relate tuberculosis prevalence to the incidence of infection, and used a model of household exposure and infection. We then incorporated evidence about age-related progression risks, BCG vaccination effi cacy, and the eff ect of HIV. This strategy is complementary to other approaches in which paediatric notifi cation data are used more directly, and synthesises a more complete picture of the epidemiology by modelling intermediate steps to disease. Because we modelled paediatric incidence starting from estimates of adult prevalence, predicted incidence in children can be compared with paediatric notifi cations to identify potential shortfalls in reporting. Many aspects of the natural history of paediatric tuberculosis, and the data used as inputs for the model, have large uncertainties. These uncertainties are fairly refl ected in the model outputs, and quantifi cation of their relative contributions helps to identify areas in which precise understanding would most improve the accuracy of our approach. The approach lends itself to automation, which means that estimates can be updated on the basis of new data.
The 22 HBCs we assessed are estimated to have 80% of the global tuberculosis burden. 6 Although the varying The household model estimates infection through household exposure, and so only includes incidence of disease from this route of infection. The community model relates infection to overall tuberculosis prevalence in adults, and aggregates all routes of infection (household and community). The density estimates are based on binning the outputs of model runs to form a histogram that represents how likely diff erent model estimates are in view of the uncertainty in the inputs. association between tuberculosis burden in adults and children by setting means these countries are likely to have a higher proportion of global paediatric tuberculosis, extrapolation of our approach would suggest a global burden that is up to 25% higher than our prediction for the 22 HBCs. Our model has identifi ed large populations that could benefi t from preventive treatment, although not all children would be eligible. In view of the effi cacy of isoniazid preventive therapy, 21, 22 children who progress to disease after household exposure should be thought to have developed preventable tuberculosis; screening of individuals sharing a household with an adult who has been diagnosed with tuberculosis and treatment of child contacts would probably substantially reduce the numbers of children who develop the disease. The large numbers predicted by our model also represent the present and accumulated result of a failure to identify and treat adults with tuberculosis eff ectively.
These estimates of child tuberculosis burden are somewhat higher than those in the 2012 WHO report, 6 similar to the notifi cation-based estimates of Nelson and colleagues (although these estimates are from more than 10 years ago), 23 and lower than the value of 1 million cases suggested by some commentators 24, 25 and the estimates of Jenkins and colleagues. 26 The comparison of notifi cations and model estimates suggests underreporting, most notably in children younger than 5 years. However, some countries do have notifi cation rates similar to estimated incidence. Further investigation is necessary to improve understanding of the reasons for the diff erence between the number of estimated and notifi ed cases in every country. In our model, India had by far the highest burden of paediatric tuberculosis, which is probably a result of its large size, demographic composition, and moderate tuberculosis prevalence.
The proportion of tuberculosis burden occurring in children has frequently been used to estimate probable paediatric burden where direct measurements do not exist. 6 Local estimates for the proportion of tuberculosis burden in children vary widely, with some investigators reporting up to 39% of the burden in children. 27 Donald 28 pointed out that increased proportions would be expected in countries where overall burden is highest, because of the correlation with younger-skewed demographics. He also noted that a high force of infection leads to a younger average age at infection, when risks of progression are highest. 28 Our model reproduces this expected trend, with proportions predicted in a similar range to estimates by Nelson and colleagues. 23 However, the countries with the largest contribution from HIV to tuberculosis incidence (South Africa and Zimbabwe) do not follow this pattern, refl ecting the lower HIV prevalence in children than adults.
As with any model, our approach involved assumptions and has limitations. The limiting assumptions were We did not have data for the age distribution of HIV infection in children, antiretroviral therapy coverage, or CD4 cell count in infected individuals; we treated HIV infection as one risk factor uniformly spread between children. Exposure to M tuberculosis and infection were not aff ected by HIV in our model, but, in reality, household clustering of HIV means that children with HIV infection could be expected to have more exposure to tuberculosis than do children without HIV infection. Although the crudeness of the approach to HIV means that our conclusions for countries with high HIV prevalences should be treated with caution, the estimate that HIV contributes to 5% of the total incidence means that this issue is likely have little eff ect on the overall estimate. The effi cacy of BCG vaccination and the causes of recorded variability remain controversial, 18 and could be aff ected by the variation in vaccine strain used. 29 In addition to incorporation of uncertain distributions that characterise the effi cacy of BCG vaccination against pulmonary and extrapulmonary tuberculosis, we considered structural model variants with unvarying BCG effi cacy by latitude. This approach might refl ect an interpretation that perceived variation of BCG vaccination effi cacy is due to masking by heterologous immunity from non-tuberculous mycobacteria. Overall disease estimates were 27% lower under this assumption (infection estimates were unaff ected).
Neither our model nor the studies on which estimates of progression were based diff erentiated between M tuberculosis infection and a positive test of M tuberculosis sensitisation. Some children are anergic and can progress to tuberculosis without ever showing evidence of sensitisation. Risks of progression were based on reports from the early 20th century in white people and might not fully apply to populations that we assessed, which can diff er systematically in factors aff ecting risks of progression, such as host genetics, dominant M tuberculosis strain types, malnutrition, or vitamin D levels. We did not consider possible correlations between risk of exposure and infection, did not take account of any previous infection protecting against reinfection, and assumed that risks of progression were concentrated in the 1-2 years after infection. We did not consider subnational heterogeneity in transmission of tuberculosis, assuming that risks of infection were proportional to prevalence. Although some of this variation will average out for overall estimates, it could be important for specifi c countries and country-level estimates, which should therefore be viewed with caution.
All model variants started from WHO estimates of adult tuberculosis prevalence, and therefore inherited their limitations. The most recent underlying demographic data were for 2010, and so we used tuberculosis, HIV, and BCG vaccination estimates for that year. We did not consider transmission of M tuberculosis from children, diff erentiate between drug-resistant and drug-susceptible tuberculosis, or include preventive treatment. 
Systematic review
We did a literature review of English language publications in PubMed, employing no date restrictions. Search terms included combinations of "mycobac*", "tuberc*", "tb", "child*", "ped*", "paed*", "burden", "epidemiology", "global", "model". We identifi ed no previous studies which had used a mechanistic model to estimate the burden of tuberculosis in children. In our model, we used offi cial estimates from WHO, the UN, DHS data and UNAIDS, and combined them with several systematic reviews to inform transitions. The reviews by Bourdin Trunz and colleagues 8 and Van Leth and colleagues 9 informed the association between tuberculosis prevalence and force of infection. The review by Fox and colleagues 12 informed risk of infection after household exposure, and the review by Marais and colleagues 15 informed the risk of progression to disease after infection. The eff ect of BCG vaccination was informed by several reviews and the eff ect of HIV was informed by the study from Hesseling and colleagues. 20 
Interpretation
Our model predicts that about 650 000 children developed tuberculosis in 2010 in the 22 countries with a high burden of the disorder. Because our estimates do not use paediatric notifi cations as a starting point, the estimates can be compared with reported cases in each country to identify shortfalls. Our model also identifi es vast numbers of children predicted to be exposed to tuberculosis every year and the even greater number of children who harbour latent tuberculosis infection.
Our approach of taking infection via household exposure as a starting point provided an independent route to estimates, but only accounted for infections occurring in the household (probably a worse assumption in older age groups). Therefore, it is reassuring and revealing that estimates from the household model are lower than, but not radically diff erent from, those from the community method, which implicitly includes all contexts of infection. In addition to those of our analysis, the household approach had its own limitations (appendix). We used notifi cation data to inform the age and sex distribution of prevalent tuberculosis in each country. Notifi cation data are subject to biases, even with restriction to smearpositive cases. However, our sensitivity analysis with a model variant assuming an age-independent distribution of tuberculosis cases in adults increased disease estimates by 11%. Detailed comparable household data were not always for 2010 and not available at all for Russia or China, and our imputations in these cases might not have captured eff ects due to any idiosyncrasies in these countries' household compositions.
In conclusion, the burden of childhood tuberculosis that we have estimated through mathematical modelling represents a substantial fraction of the total global tuberculosis burden. The estimated incidence is higher than that of paediatric notifi cations, with under-reporting most acute in the youngest ages. Our model also predicts high numbers of children with household exposure to M tuberculosis and infection, many of whom will go on to develop disease. Eff ective household contact tracing and preventive therapy could have a substantial eff ect on these preventable future cases.
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